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Total chemical protein synthesis was used to generate multimilli-
gram quantities of the mechanosensitive channel of large conduc-
tance from Escherichia coli (Ec-MscL) and Mycobacterium tubercu-
losis (Tb-MscL). Cysteine residues introduced to allow chemical
ligation were masked with cysteine-reactive molecules, resulting in
side chain functional groups similar to those of the wild-type
protein. Synthetic channel proteins were transferred to 2,2,2-
trifluoroethanol and reconstituted into vesicle membranes. Fluo-
rescent imaging of vesicles showed that channel proteins were
membrane-localized. Single-channel recordings showed that re-
constituted synthetic Ec-MscL has conductance, pressure depen-
dence, and substate distribution similar to those of the recombi-
nant channel. Reconstituted synthetic Tb-MscL also displayed
conductance and pressure dependence similar to that of the
recombinant protein. Possibilities for the incorporation of unnat-
ural amino acids and biophysical probes, and applications of such
synthetic ion channel analogs, are discussed.
Recently, ion channel research has been aided by the discoveryof bacterial ion channels that share many key features of
mammalian channels (1–3). Some of these bacterial channel
proteins are smaller and more amenable to expression and
purification than mammalian channels. Importantly, bacterial
channels can often be reconstituted into vesicles and other
synthetic membrane systems, allowing detailed functional char-
acterization (4–6). Furthermore, several bacterial channels have
been described at atomic resolution by x-ray crystallography
(7–11), providing opportunities for correlating structure and
function in a key class of membrane protein.
Although the preparation of many medium-sized water-
soluble proteins by chemical ligation is now a routine procedure
(12–14), the synthesis of ion channels and other membrane
proteins presents unique challenges. Many hydrophobic peptides
have sequences that couple inefficiently, meaning that the
synthesis of each segment must be optimized. Hydrophobic
peptides also have limited solubility and tend to aggregate.
Furthermore, after synthesis is complete the native oligomeric
protein must be formed from unfolded monomers. However,
recent advances in chemical ligation methodologies have per-
mitted the semisynthesis (15) and the total chemical synthesis of
membrane proteins, including the 97-residue type III (single
membrane-spanning segment) M2 protein of the influenza virus
(16). The synthetic M2 protein assembled into the native tet-
rameric form on reconstitution into dodecylphosphocholine
micelles.
Here, we describe the chemical synthesis of two polytopic
membrane proteins, the mechanosensitive ion channels from
Escherichia coli (Ec-MscL) and Mycobacterium tuberculosis (Tb-
MscL), and the vesicle reconstitution of these channels into a
form functionally similar to that of the recombinant protein.
Multimilligram quantities of Ec-MscL and Tb-MscL were gen-
erated by optimizing synthesis, purification, and ligation proto-
cols previously developed for producing hydrophobic membrane
proteins, thus allowing vesicle reconstitution, and then patch-
clamp analysis. The ability to synthesize, reconstitute, and func-
tionally characterize ion channels presents new possibilities for
ion channel research. Unnatural amino acids and fluorescent or
EPR spin-labels can now be incorporated site-specifically, al-
lowing a variety of detailed investigations into channel function.
Also, ion channels are sensitive chemical sensors, producing
detectable signals from single-molecule events. Therefore, syn-
thetic channels could allow the development of novel biosensors
or bioelectronic materials.
Materials and Methods
Peptide Synthesis and RP-HPLC Purification. Peptide segments were
synthesized on either a thioester-generating resin (17) or a
(–O–CH2)–phenylacetamidomethyl resin by using standard tert-
butoxycarbonyl chemistry with in situ neutralization (18), then
cleaved and deprotected with hydrogen fluoride at 0°C in the
presence of p-cresol. Acetamidomethyl (Acm) was used as a
nonstandard side chain protecting group for cysteine residues to
inhibit self-ligation during segment assembly, and the N-terminal
segment was biotinylated on-resin by using a 10-fold molar excess
of NHS-biotin (Novabiochem) in anhydrous DMSO (Sigma-
Aldrich). Target peptides were solubilized with mixtures of water
and 2,2,2-trif luoroethanol (TFE) (Sigma-Aldrich) and purified
by preparative RP-HPLC on a Rainin Instruments Dynamax
system with a 2.2 (i.d.)  25-cm (10-m particle size) Vydac
(Hesperia, CA) C4 column. Electrospray ionization (ESI)-MS
was performed on either a PE Sciex (Thornhill, ON, Canada)
API-III triple quadrapole or an API-150 single quadrapole mass
spectrometer to identify the target peptides. Theoretical peptide
masses (average isotope composition) were calculated by
MACPROMASS (T. Lee, City of Hope, Duarte, CA), and experi-
mental masses were calculated by reconstruction from ESI-MS
data in MACSPEC (PE Sciex) or ANALYST (MDS Sciex, Concord,
ON, Canada). Peptide purity was assessed on a 0.46 (i.d.) 
15-cm Vydac C4 column (5-m particle size), using a Hewlett–
Packard 1100 quaternary pump high-pressure mixing system
(see Supporting Materials and Methods, which is published as
supporting information on the PNAS web site, for more detail
on experimental procedures).
Chemical Protein Synthesis, Purification, and Transfer to TFE. Liga-
tions were performed with peptide concentrations of 0.1 mM in
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48 mM dodecylphosphocholine (DPC) (Avanti Polar Lipids) and
8 M urea in 250 mM phosphate buffer (pH 7.5) at 40°C.
Reactions were initiated by the addition of 0.5% thiophenol
(Fluka) and monitored by analytical RP-HPLC and ESI-MS
analysis. Ligated product was treated with a 5-fold excess
(volvol) of 20% 2-mercaptoethanol (Fluka) in 48 mM DPC8
M urea solution (pH 5) at 40°C for 5 min, then with Tris-
carboxyethyl phosphine (TCEP) (Fluka Chemicals) for a further
3 min. The product from the first ligation was purified by
preparative C4 RP-HPLC over 20 min on a 35–65% gradient of
buffer C [6:3:1, isopropanol:acetonitrile:water with 0.1% trif lu-
oroacetic acid (Halocarbon, River Edge, NJ)]. The Acm pro-
tecting group on the N-terminal cysteine residue was removed
from this product by reaction for 45 min with a 15-fold molar
excess of Hg(II) acetate (Fluka). 2-mercaptoethanol was added
to this solution to a concentration of 2% (volvol) and reacted
for 15 min to scavenge Hg2, and then TCEP was added.
Deprotected product was purified on a 45–65% gradient of
buffer C over 5 min, and the material was pooled and lyophilized.
Product from the second and final ligation was purified on a
55–75% gradient over 15 min, and the sulfhydryl groups were
modified at room temperature (pH 7.5) with a 30-fold molar
excess of bromoacetamide (Sigma-Aldrich). Full-length biotin-
ylated, cysteine-modified Ec-MscL(1–136) was then purified on
a 60–80% gradient of buffer C over 25 min. Similar methods of
chemical synthesis and purification were used to produce syn-
thetic Tb-MscL.
Pure synthetic Ec-MscL and Tb-MscL were transferred from
HPLC buffers to TFE by addition of 5 vol of freshly distilled TFE
to the HPLC pool, adjustment of the pH to 7 with ammonia, and
sample volume reduction, by evaporation under vacuum, to give a
final product concentration of 2 mgml (see Supporting Materials
and Methods for more detail on experimental procedures).
Vesicle Reconstitution of Synthetic and Recombinant Ec-MscL. Fifty
microliters of a 10 mgml solution of azolectin (Sigma-Aldrich)
in chloroform was air-dried on Teflon for 15 min, redissolved
with 5 l of a 2 mgml solution of synthetic channel protein in
TFE (19), and allowed to dry for 15 min. The resultant film of
material was desiccated under house vacuum for 1 h and then
rehydrated for 1 h with 5 l of 250 mM KCl5 mM Hepes0.1
mM EDTA (20). One microliter of this rehydrated lipid was
applied to the glass coverslip of the recording chamber and
allowed to air dry for 10 min, and 0.5 l of 1 M MgCl2 was spread
on the coverslip and dried for 10 min. Three hundred microliters
of rehydration buffer was then added to the recording chamber,
and blister formation was allowed to proceed for 30 min. Control
samples were prepared in a similar manner. These vesicle
preparations were the starting point for both fluorescence and
patch-clamp experiments. After transfer to TFE, WT recombi-
nant Tb-MscL was also vesicle-reconstituted for electrophysio-
logical measurements (see Supporting Materials and Methods for
more detail on experimental procedures).
Fluorescence Imaging. Two microliters of a 0.1 mgml solution of
streptavidin-Alexa Fluor 488 conjugate (Molecular Probes) in
PBS was added to vesicle preparations containing reconstituted
synthetic Ec-MscL or Tb-MscL, or lacking channel protein.
Vesicles were observed during 1 h on an Olympus IX71 inverted
microscope equipped with a shuttered 175-W xenon arc lamp, a
488-nm excitation filter, a 515-nm fluorescence cube, and an
Olympus Plan Apo 601.4 numerical aperture (N.A.) oil
immersion objective. Images were captured on a Photometrix
(San Diego) Cascade charge-coupled device camera. Exposure
times were 100 ms for brightfield images and 200–300 ms for
fluorescence images.
Electrophysiological Characterization. Single-channel recordings
were made at 20–22°C on synthetic Ec-MscL and Tb-MscL, and
on recombinant Ec-MscL at a bandwidth of 20 kHz at 50 mV
(intracellular medium is negative) in symmetrical 250 mM KCl1
mM MgCl25 mM Hepes (pH 7.1) solution. Currents were
acquired with an Axopatch 200B amplifier, a Digidata 1322A
digitizer, and PCLAMP 8 software (all from Axon Instruments,
Union City, CA). The probability of opening (Popen) vs. suction
curves were generated by software designed by one of the
authors (G.S.). Boltzmann distributions were fitted to the dose–
response relations by using ORIGIN 6.0 software (Microcal,
Northampton, MA), yielding activation midpoints and gradients.
The curves on the all-points histograms were normalized to
match the areas under the peaks corresponding to fully open
states of synthetic and recombinant Ec-MscL.
Results
Synthetic Strategy. The general strategy used for the total chem-
ical synthesis of Ec-MscL is shown in Fig. 1. A challenge for the
chemical synthesis of Ec-MscL and Tb-MscL was the absence
of cysteine residues in the WT sequence (21, 22); introduction of
cysteine residues at ligation sites results in the presence
of nonnative sulfhydryl groups in the final protein. For the
synthesis of Ec-MscL, glutamine 56 (Q56) and asparagine 103
(N103) were changed to cysteine, based on unpublished data
(J.A.M.) indicating that these side chains are not critical to
channel function. To minimize contributions from nonnative
groups in the target sequence, the full-length protein was reacted
with bromoacetamide (23), which selectively modifies the two
introduced cysteine residues and produces side chain functional
groups that are sterically and electronically similar to those of the
WT residues. For the synthesis of Tb-MscL, glutamate 102
(E102) and serine 52 (S52) (22) were changed to cysteine and
then masked in the final product with appropriate cysteine-
reactive molecules (Fig. 5, which is published as supporting
information on the PNAS web site). Both synthetic strategies
also incorporated an N-terminal biotin moiety during segment
synthesis to aid in fluorescent labeling.
Multimilligram Quantities of Channel Protein Were Generated by
Using an Optimized Synthesis Procedure. A particular concern in the
total chemical synthesis of membrane proteins is the difficulty in
preparing and handling the hydrophobic peptide segments.
However, by using an optimized in situ peptide synthesis protocol
and including a TFE solubilization step into the purification
procedure to overcome the limited solubility of the peptide
segments, we achieved final yields of 25–30% for Ec-MscL(56–
102) and Ec-MscL(103–136), and 15% for Ec-MscL(1–55).
Yields of 15–30% were also observed for the Tb-MscL segments.
Target peptides were 95% pure by analytical RP-HPLC anal-
ysis. Experimental masses of the segments were within 1 Da of
the theoretical mass. For Ec-MscL segments, masses were as
follows: MscL(1–55)--thioester, experimental mass  6,217.5
(1) (theoretical mass  6,218.1 Da); MscL(56–102)--
thioester, experimental mass 5,698.5 (1) (theoretical mass
5,698.4 Da); and MscL(103–136)-carboxylate, experimental
mass  3,217.5 (1) (theoretical mass  3,218.1Da).
The limited solubility of the peptide segments in ligation
buffers was overcome by the use of increased temperature
(40°C), high denaturant concentration (8 M urea), and the
addition of DPC to ligation reactions. Pure ligated product was
obtained by using isopropanol-containing buffer gradients sim-
ilar to those used for peptide segment purification. Subsequent
treatment of the HPLC pool of pure material with an excess of
Hg(II) acetate for 45 min resulted in the quantitative removal of
the Acm protecting group from the N-terminal cysteine residue.
Purification of this deprotected product, Ec-MscL(56–136),
after 2-mercaptoethanol and TCEP treatment resulted in ma-








terial [experimental mass  9,138.5 (1.5) (theoretical mass 
9,137.8 Da)] of95% purity as assessed by analytical RP-HPLC.
Similar buffer conditions also efficiently solubilized reactant
peptides in the final ligation reactions, and comparable purifi-
cation protocols yielded pure ligated product. Attempts at
modifying cysteine residues with bromoacetamide directly in the
HPLC pool resulted in very slow and incomplete reactions.
Quantitative modification of cysteine residues was achieved by
performing this reaction after a 4-fold concentration of the pool
by lyophilization in the presence of DPC. Purification yielded
correctly modified product [Ec-MscL, experimental mass 
15,266.5 (2) (theoretical mass  15,265.8 Da); Tb-MscL,
experimental mass 16,301.5 (2) (theoretical mass 16,300.7
Da)], and RP-HPLC analysis of synthetic Ec-MscL (Fig. 2) and
Tb-MscL (Fig. 6, which is published as supporting information
on the PNAS web site) showed that the final product was 95%
pure. Yields of between 20% and 50% were achieved for
purification of ligated and modified Ec-MscL and Tb-MscL
segments. Final yields of pure, modified full-length protein for
both Ec-MscL and Tb-MscL were 4 mg.
Transfer of the synthetic channel to an organic solvent able to
dissolve dialkylphospholipid was a necessary step for vesicle
reconstitution. Initial attempts to transfer synthetic protein to
TFE resulted in only partial solubilization (0.5 mgml). When
the volume of TFE added to the HPLC pool was increased and
the pH was adjusted before and during transfer, clear solutions
of synthetic Ec-MscL and Tb-MscL (2 mgml) were obtained.
RP-HPLC and ESI-MS analysis of these TFE solutions showed
that modifications had not occurred during buffer transfer.
Vesicle Formation in the Recording Chamber Reliably Produces Blis-
ters. Vesicle reconstitution was performed to fold synthetic
Ec-MscL and Tb-MscL into their native conformation, in a lipid
bilayer system amenable to fluorescence and electrophysiology
experiments. The first step of this process involved forming an
azolectin film on a Teflon slide, then redissolving this film with
an aliquot of synthetic channel in TFE. This resulted in a layer
of lipid and protein on the Teflon having the desired molar ratio
(1,000:1). After desiccation and rehydration of this film, high
concentrations of multilamellar vesicles were observed by light
microscopy. However, very few blisters developed when aliquots
of this vesicle preparation were transferred to a recording
chamber with Mg2-containing solution. Large increases in the
number of blisters were achieved by applying an aliquot of the
lipid preparation and of concentrated MgCl2 solution directly to
the recording chamber, then drying and rehydrating the result-
ant film. Furthermore, vesicles in these preparations adhered to
the bottom of the recording chamber, simplifying the search for
blisters suitable for subsequent patch-clamp experiments.
Fig. 1. Strategy for the total chemical synthesis of Ec-MscL. The major steps of the synthesis are listed numerically. Peptide sequences are as follows:
(biotin)-MscL(1–55)--thioester, MSIIKEFRE FAMRGNVVDLAVGVIIGAAFGKIVSSLVADIIMPPLGLLIG GIDFK; MscL(56–102)--thioester (Q56C), FAVTLRDAQG-
DIPAVVMHYGVFIQNVF DFLIVAFAIFMAIKLI NKL; MscL(103–136)-carboxylate (N103C), RKKEEPAAAPAP TKEEVLLTEIRDLLKEQNNRS. The Acm cysteine protecting
group, the biotin moiety, and the C-terminal -thioester group (COSR; R, auxiliary amino acid) are shown in green. The structures of the N-terminal modifying
groups are shown in the lower left of the figure, and the expected topology of the channel protein in the phospholipid bilayer is shown at the lower right of
the figure. Relevant amino acids are indicated on this topological map to define the limits of the probable transmembrane helices (TM1, L19-A38; TM2, A70-I96),
as listed on the Swiss-Prot database (http:us.expasy.org; entry P23867), and the ligation sites (cysteine residues), which are also shown in red.
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Ec-MscL and Tb-MscL Are Membrane-Localized After Vesicle Recon-
stitution. The N-terminal biotin moieties of Ec-MscL and Tb-
MscL were modified with streptavidin-Alexa Fluor 488 to allow
fluorescence imaging. Brightfield and fluorescence images of
vesicle preparations generated in the presence and the absence
of synthetic Ec-MscL are shown in Fig. 3. Fluorescence images
of vesicles prepared in the presence of channel protein clearly
show strong fluorescence localized to the membrane portion,
weaker and more disperse fluorescence in the lumen of the
vesicle, and little or none in solution (Fig. 3 B and D). This
membrane-localized fluorescence was first observed 10 min after
the addition of fluorescent label, and increased in intensity over
1 h. After 1 h, all of the vesicles located by brightfield microscopy
and then viewed in the focal plane also showed membrane-
localized fluorescence. In contrast, the control sample showed
only diffuse fluorescence in the solution and no membrane-
localized fluorescence even several hours after the addition of
the fluorescent label (Fig. 3F). Fluorescence experiments on
vesicle-reconstituted Tb-MscL show similar results (Fig. 7, which
is published as supporting information on the PNAS web site).
The results of these fluorescence experiments demonstrate that
synthetic Ec-MscL and Tb-MscL have associated with the vesicle
membrane during the reconstitution procedure.
Tension-Gated Single-Channel Activity in Vesicle-Reconstituted Syn-
thetic Ec-MscL. Patch-clamp experiments were performed to
assess correct folding of vesicle-reconstituted synthetic Ec-MscL.
The vesicle preparations yielded patches with resistances of 5–20
G. Single-channel activity was recorded and analyzed from
20 patches. Suction produced characteristic single-channel
activity. Brief (10 ms) partial and full channel openings were
first observed at a suction of0.7 psi (1 psi 6.89 kPa), whereas
sustained channel openings were observed at0.9 psi (Fig. 4A).
In some patches, multiple superimposed openings were observed
Fig. 2. RP-HPLC and ESI-MS analysis of synthetic Ec-MscL. (A) Analytical RP-HPLC chromatogram (25–100% buffer C, 26 min) for the final product. (B) ESI mass
spectrum with the observed charge states labeled. (C) Mass reconstruct from the charged states (minor peaks in the ESI-MS reconstruct showing masses slightly
greater than the target peptide are Na adducts).
Fig. 3. Fluorescence imaging of vesicle-reconstituted synthetic Ec-MscL. A and C show brightfield images of vesicles generated in the presence of synthetic
Ec-MscL, and B and D show the corresponding fluorescence images. Several vesicles or groups of vesicles are indicated by arrows in A and C, and the lumen of
the large vesicle in A is indicated by a filled circle. The arrow in A also indicates the vesicle membrane. Vesicles in these preparations are attached to the bottom
of the recording chamber. E and F show the brightfield and corresponding fluorescence image of vesicles generated in the absence of synthetic Ec-MscL. Regions
of diffuse fluorescence observed in B and D result from vesicles not in the focal plane.








at higher suction (Fig. 4A). When suction was released, all
channel activity disappeared. No corresponding conductance
was observed when suction was applied to patches formed from
vesicles produced in the absence of channel protein. In general,
the electrophysiological features of synthetic Ec-MscL activity
closely resemble those observed for recombinant Ec-MscL (24–
26): open-channel conductance of 3 nS; the presence of multiple
substates; and the overall sensitivity to suction (24–26).
Synthetic and WT Ec-MscL Have Similar Activation Thresholds and
Comparable Substate Conductances. Probability of opening (Popen)
vs. suction curves and all-points histograms allowed more de-
tailed kinetic comparison of synthetic and recombinant Ec-
MscL. For these analyses, conductance recordings were made on
multiple-channel patches while a ramp of suction was applied.
Dose–response (suction–Popen) relationships for recombinant
(solid squares) and synthetic (open circles) Ec-MscL are shown
in Fig. 4B. The average midpoints (SEM) of these curves are
xo  1.0  0.1 psi (7  1 kPa, 6 traces) for synthetic and 1.3 
0.1 psi (9  1 kPa, 10 traces) for recombinant Ec-MscL. The
small difference in midpoints does not, in our judgment, reveal
a significant difference in the suction sensitivity of synthetic
Ec-MscL vs. recombinant Ec-MscL. Also, the similar average
gradient at the midpoint of the dose–response curves ( 0.06
0.01 psi for both synthetic and recombinant channel) shows equal
suction dependence on gating. The ratio xo is 0.05 for recom-
binant Ec-MscL and 0.06 for synthetic Ec-Mscl, in agreement
with the value of 0.05 (0.01 for all ratios) reported previously
(25). The all-points histograms generated from traces containing
either 1 or 2 channels (eight traces for recombinant and five
traces for synthetic Ec-MscL) are shown in Fig. 4C. These data
show that both synthetic and recombinant Ec-MscL occupy
conductance substates for5% of the time spent in the highest-
conductance open state. The all-points histograms were fitted to
multiple Gaussian components to reveal substate conductances;
these substate conductances were equal for the synthetic and
recombinant channels (vertical lines in Fig. 4C), suggesting that
the structural trajectory of channel opening is similar for both
synthetic and recombinant Ec-MscL.
The Increased Pressure Response of Synthetic Tb-MscL Mimics That of
Recombinant Tb-MscL. Electrophysiological studies were also per-
formed on vesicle-reconstituted synthetic Tb-MscL. Single-
channel openings (five traces acquired, one shown in Fig 8, which
is published as supporting information on the PNAS web site)
showed typical mechanosensitive single-channel activity, with
conductance similar to that of synthetic Ec-MscL (3 nS) and
recombinant Tb-MscL (5). As with recombinant Tb-MscL (5, 6),
2-fold greater suction (2 psi) was needed to achieve channel
opening of synthetic Tb-MscL, as compared to synthetic or
recombinant Ec-MscL. In most traces, channel openings of
synthetic Tb-MscL were followed by membrane rupture (max-
imum observed Popen was 0.1), and so it was not possible to
perform detailed analyses similar to those described previously
for Ec-MscL. However, to the extent that such characterization
was possible, synthetic Tb-MscL is functionally similar to re-
combinant Tb-MscL.
Discussion
Chemical protein synthesis has provided multimilligram quan-
tities of unfolded synthetic biotinylated Ec-MscL and Tb-MscL
for vesicle reconstitution and electrophysiological characteriza-
tion. Cysteine residues required for chemical ligation were
masked by modification with cysteine-reactive compounds, re-
sulting in side chain functional groups similar to those of the WT
protein (23). Subsequent electrophysiological characterization
showed that the small differences in the side chain length of these
residues did not affect channel function. A robust and repro-
ducible protocol for producing a biotinylated version of synthetic
Ec-MscL and Tb-MscL was developed by making key improve-
ments to current protocols, such as the addition of organic
solvent and detergent during purification and ligation, and by
performing the deprotection and modification of cysteine resi-
dues without full lyophilization and redissolution. This opti-
mized synthesis protocol appears generally applicable because
Ec-MscL, Tb-MscL, and several f luorescently labeled analogs of
Ec-MscL (data not shown) were successfully made.
Synthetic Ec-MscL and Tb-MscL were reconstituted into
vesicles. Key features of the protocol are the transfer of the
channel protein from RP-HPLC buffers to TFE by evaporative
Fig. 4. Electrophysiological analysis of vesicle-reconstituted Ec-MscL. (A) A
sample trace of synthetic Ec-MscL activity (upper trace) during a ramp of
applied suction (lower trace). (B) Dose–response (suction–Popen) relations for
synthetic (open circles) and recombinant (filled squares) Ec-MscL. Also shown
in B are the average midpoint values and standard errors calculated from the
6 and 10 Popen vs. suction curves, respectively. (C) All-points histograms for
synthetic and recombinant Ec-MscL generated from five and eight conduc-
tance traces, respectively. Dashed vertical lines on C emphasize the similar
conductance substates of synthetic and recombinant Ec-MscL.
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solvent exchange; the redissolution of a dry azolectin film with
this TFE solution containing channel protein; and the final
rehydration of vesicles and divalent cation-induced blister for-
mation in the recording chamber. The incorporation of the
N-terminal biotin moiety during segment synthesis allowed a
fluorescent label to be used to establish membrane-localization
of Ec-MscL and Tb-MscL.
Vesicle preparations generated directly in the electrophysio-
logical recording chamber contained numerous blisters suitable
for producing G seals in patch-clamp experiments. Further-
more, the level of mechanosensitive ion channel activity found
in excised patches indicated that the reconstitution protocol is
highly efficient. Recordings from excised patches containing
either synthetic or recombinant Ec-MscL, and the subsequent
analyses, indicate that synthetic Ec-MscL is functionally the same
as recombinant Ec-MscL: the single-channel conductance (3 nS)
is similar for both channels; similar conductance substates are
present; and there is little or no difference in their suction
sensitivity. The conductance and gating characteristics of syn-
thetic Tb-MscL mimicked those of recombinant Tb-MscL. The
functional similarities observed between synthetic and recom-
binant channels demonstrate that they have folded to their native
oligomeric structures.
The ability to synthesize, reconstitute, and electrophysiologi-
cally characterize ion channels provides many new possibilities
for further investigation. A wide range of chemical modifications
can now be introduced with the precise control that total
chemical synthesis allows (23, 27–28). For example, f luorescent
unnatural amino acids can be introduced (29–31), allowing a
more direct, and so more quantitative, f luorescence-imaging
approach than the biotin-streptavidin Alexa Fluor 488 protocol
used here. Fluorescently labeled analogs will allow a variety of
fluorescence resonance energy transfer (FRET) studies to be
performed, and may also allow the simultaneous recording of
single-channel conductance and single-molecule FRET. We
anticipate that the present synthesis and vesicle-reconstitution
protocols will be broadly applicable to studies on diverse ion
channels.
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